პატივისცემით,

გვანცა გასვიანი
ჯანმრთელობის დაცვის დეპარტამენტი,
საქართველოს შრომის, ჯანმრთელობისა და სოციალური დაცვის სამინისტრო.
აკ.წერეთლის 144.  0119. ქ.თბილისი, საქართველო.
(+995) 595 053609; (+995) 32 510038 1116.

Sincerely,

g) What costs would arise from the treatment (therapy with Pazopanib; if need be, other chemotherapy; and palliative care) in Georgia?

In Georgian pharmaceutical market, the cost of Pazopanib 400mg (trade name - Votrient) is 3400 GEL. Since the cost of the pazopanib (Votrient) is not covered under the Universal Health Care Program and the course of treatment therapy is planned in accordance with the patient’s individual health condition, it’s impossible to define the cost of chemotherapy in advance.

As for the Trabectidine, this medicine is not registered in Georgia. According to the Georgian legislation, after submitting the relevant documentation to the LEPL State Regulation Agency for Medical Activities, individual drug purchase (registration) can be performed by the request of the patient. Though, it should be mentioned that in case individual registration, the price of medication can be different in different cases.

პალიატიური მკურნალობის ფასები გვჭირდება კატეგორიების მიხედვით.

h) Would the patient have to pay for the aforementioned components of the treatment herself? 

i) Are parts of the therapy or is the therapy in its entirety covered by the state of Georgia?

a. If yes, to what extent would costs be covered?

b. If yes, what are the preconditions for a patient to receive coverage of the costs of the therapy?

Since, the Pazopanib and Trapidine is not covered by the State Program, patient should pay by himseld either address to the “Referral Service Commission”, which functions under the Ministry of Labour, Health and Social Affairs of Georgia. financing of the services that are not covered by the State Program could be considered by the "Referral Service Commission" after receiving necessary documentation from the patient/service provider. The cases might be financed once in requested amount, once – partially, twice – partially and neither of the cases. The decision of financing is made by the commission individually in each case.

It would be of great help to us, if the MoH could provide us with a tableau as to what forms of co-financing exist and which parts of the population have to contribute which percentage for the treatments. Do you happen to have a catalogue of the relevant rates applicable to the different groups of patients? I think that this information would also be useful to us in other, similar cases.

Universal Health Care Program beneficiaries are divided into categories, according to the revenue. Therefore, some medical services are provided to certain categories with 100 per cent financing, some services – 90 percent financing, some – 70 percent and for some categories neither of services are funded. In case of providing Georgian citizen’s ID number with indication the type of medical services, the Ministry could provide more detailed information about medical service financing in each cases.